Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Techinvention Lifecare has been engaged by Botswana Vaccine Institute for its Veterinary Vaccine…
The project commenced in 2022 and is expected to be completed and operational by 2026
Signet Therapeutics announces IND approval by the FDA for world’s first targeted therapy for DGC
Sigx1094 is also reportedly the first of a series of pipeline projects that was discovered by AI and validated by organoid disease…
Navigating investment trends in dietary supplement markets
Express Pharma–Nutrify Today Boardroom: Season 2 | EP 2
Amylyx looks to cover financial gap left by Relyvrio with avexitide deal, says GlobalData
The acquisition is a strategic action by Amylyx following the failure of its lead amyotrophic lateral sclerosis (ALS) therapy,…
OPPI urges government to boost R&D and innovation in pharma sector ahead of Union Budget
Anil Matai, Director General of OPPI, highlights key recommendations for enhancing pharmaceutical development in India
How AI is impacting ideation to commercialization in nutraceuticals
Express Pharma–Nutrify Today Boardroom: Season 2 | EP 1
AstraZeneca’s COVID prevention drug application gets EU fast-track assessment
An accelerated assessment aims to speed up the European Medicines Agency’s (EMA) review of a market authorisation application
Alembic Pharma announces USFDA Tentative Approval for Bosutinib Tablets, 100 mg and 500 mg
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)
US body Clinical and Laboratory Standards Institute (CLSI) awards high susceptibility breakpoints to…
Currently, Zaynich is undergoing a multinational Phase 3 study, which is expected to be completed by FY 2025
Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base:…
Pharmaceutical manufacturers like Boehringer Ingelheim, GSK, and AstraZeneca are participating in this initiative